Patients' demographic and clinical characteristics
| Variable . | FCR . | 90YFC . | P . |
|---|---|---|---|
| No. of patients | 47 | 26 | |
| Median age, y (range) | 53 (33-68) | 55 (29-66) | .3 |
| Sex, no. (%) | |||
| Male | 25 (53) | 16 (61) | .3 |
| Female | 22 (47) | 10 (38) | |
| Lactate dehydrogenase > normal, no. (%) | 12 (25) | 5 (20) | .4 |
| Median β2-microglobulin, Mg/L (range) | 2 (1.2-6.5) | 2 (0.6-3.3) | .2 |
| PET+, no./total (%) | 7 (15) | 11/25 (44) | .01 |
| 111Ibrituximab-positive scan, no./total (%) | 0 | 10/25 (40) | |
| No. of prior chemotherapies, median (range) | 3 (2-7) | 3 (2-7) | .7 |
| Prior autologous transplantation, no. (%) | 9 (19) | 0 | |
| Grade, no. (%) | .6 | ||
| 1 or 2 | 37 (79) | 21 (81) | |
| 3 | 10 (21) | 3 (12) | |
| Nonspecified | 0 | 2 (7) | |
| Median time from diagnosis to transplantation, y (range) | 3 (0.7-24) | 2 (1.1-13.1) | .2 |
| Disease status at transplantation, no. (%) | < .001 | ||
| CR | 18 (38) | 8 (31) | |
| Partial remission | 29 (52) | 8 (31) | |
| Chemorefractory | 0 | 10 (38) | |
| Stem cell source, no. (%) | < .001 | ||
| Matched related | 45 (96) | 15 (58) | |
| Matched unrelated | 2 (4) | 8 (31) | |
| Mismatched related | 0 | 1 (4) | |
| Mismatched unrelated | 0 | 2 (8) |
| Variable . | FCR . | 90YFC . | P . |
|---|---|---|---|
| No. of patients | 47 | 26 | |
| Median age, y (range) | 53 (33-68) | 55 (29-66) | .3 |
| Sex, no. (%) | |||
| Male | 25 (53) | 16 (61) | .3 |
| Female | 22 (47) | 10 (38) | |
| Lactate dehydrogenase > normal, no. (%) | 12 (25) | 5 (20) | .4 |
| Median β2-microglobulin, Mg/L (range) | 2 (1.2-6.5) | 2 (0.6-3.3) | .2 |
| PET+, no./total (%) | 7 (15) | 11/25 (44) | .01 |
| 111Ibrituximab-positive scan, no./total (%) | 0 | 10/25 (40) | |
| No. of prior chemotherapies, median (range) | 3 (2-7) | 3 (2-7) | .7 |
| Prior autologous transplantation, no. (%) | 9 (19) | 0 | |
| Grade, no. (%) | .6 | ||
| 1 or 2 | 37 (79) | 21 (81) | |
| 3 | 10 (21) | 3 (12) | |
| Nonspecified | 0 | 2 (7) | |
| Median time from diagnosis to transplantation, y (range) | 3 (0.7-24) | 2 (1.1-13.1) | .2 |
| Disease status at transplantation, no. (%) | < .001 | ||
| CR | 18 (38) | 8 (31) | |
| Partial remission | 29 (52) | 8 (31) | |
| Chemorefractory | 0 | 10 (38) | |
| Stem cell source, no. (%) | < .001 | ||
| Matched related | 45 (96) | 15 (58) | |
| Matched unrelated | 2 (4) | 8 (31) | |
| Mismatched related | 0 | 1 (4) | |
| Mismatched unrelated | 0 | 2 (8) |